FDA's acts on Plan B faulted view story
Tuesday, November 15, 2005 Jonathan D. Rockoff - - Baltimore Sun
| Top officials at the Food and Drug Administration told staff members they would reject over-the-counter sales of the "morning after" pill months before agency scientists finished safety reviews, congressional investigators said yesterday in a report that sparked renewed criticism that abortion politics is infecting government science.
|
wireless
my file
comments
view story